MediWound Ltd. $MDWD is Yelin Lapidot Holdings Management Ltd.’s 9th Largest Position

Yelin Lapidot Holdings Management Ltd. cut its stake in shares of MediWound Ltd. (NASDAQ:MDWD) by 4.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 816,741 shares of the biopharmaceutical company’s stock after selling 41,259 shares during the quarter. MediWound accounts for approximately 2.9% of Yelin Lapidot Holdings Management Ltd.’s holdings, making the stock its 9th biggest position. Yelin Lapidot Holdings Management Ltd. owned approximately 0.08% of MediWound worth $15,820,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Corebridge Financial Inc. grew its holdings in MediWound by 17.1% during the first quarter. Corebridge Financial Inc. now owns 4,559 shares of the biopharmaceutical company’s stock worth $71,000 after acquiring an additional 665 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in MediWound by 22.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,452 shares of the biopharmaceutical company’s stock worth $85,000 after acquiring an additional 999 shares during the last quarter. Deutsche Bank AG lifted its stake in MediWound by 2,255.2% in the 1st quarter. Deutsche Bank AG now owns 6,312 shares of the biopharmaceutical company’s stock valued at $98,000 after buying an additional 6,044 shares in the last quarter. Nuveen LLC purchased a new stake in shares of MediWound in the first quarter valued at $168,000. Finally, Rhumbline Advisers boosted its stake in shares of MediWound by 4.4% during the 1st quarter. Rhumbline Advisers now owns 11,316 shares of the biopharmaceutical company’s stock worth $176,000 after purchasing an additional 481 shares during the last quarter. Institutional investors and hedge funds own 46.83% of the company’s stock.

MediWound Stock Performance

Shares of MediWound stock opened at $18.03 on Friday. The company has a 50-day simple moving average of $17.83 and a two-hundred day simple moving average of $18.82. MediWound Ltd. has a one year low of $14.14 and a one year high of $22.50. The company has a market capitalization of $199.90 million, a PE ratio of -6.83 and a beta of 0.22.

MediWound (NASDAQ:MDWD) last announced its earnings results on Thursday, August 14th. The biopharmaceutical company reported ($1.23) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.68). The firm had revenue of $5.71 million during the quarter, compared to analyst estimates of $5.68 million. MediWound had a negative net margin of 142.18% and a negative return on equity of 96.71%. On average, equities analysts predict that MediWound Ltd. will post -2.66 earnings per share for the current fiscal year.

Analyst Ratings Changes

MDWD has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of MediWound in a research report on Wednesday, October 8th. Zacks Research lowered MediWound from a “hold” rating to a “strong sell” rating in a research report on Monday, October 13th. Finally, Wall Street Zen cut shares of MediWound from a “hold” rating to a “sell” rating in a research report on Friday, July 18th. Four research analysts have rated the stock with a Buy rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $32.25.

MediWound Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.